| RPHM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the RPHM shares outstanding history going back to 4/9/2021:
Also see: RPHM Market Cap History RPHM YTD Return |
As of 8/8/2024 Reneo Pharmaceuticals has 33.43 million RPHM shares outstanding. Investors often track the RPHM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RPHM share count trends over time, with 15 historical shares outstanding datapoints presented, dating back to 4/9/2021.

| RPHM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the RPHM shares outstanding history going back to 4/9/2021:
Also see: RPHM Market Cap History RPHM YTD Return |
| RPHM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||
RPHM Historical Shares Outstanding: +10.16% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| RPHM Stock Price Chart |
| About OnKure Therapeutics Inc |
| Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate. Co.'s primary product candidate, REN001, is a potent and selective agonist of the peroxisome proliferator-activated receptor delta. Co. is developing REN001 in rare genetic diseases that typically present with myopathy and have high unmet medical needs, including primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. We show 15 historical shares outstanding datapoints in our coverage of RPHM's shares outstanding history. Understanding the changing numbers of RPHM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RPHM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RPHM by allowing them to research RPHM shares outstanding history as well as any other stock in our coverage universe. |
| RPHM Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RPHM Share Performance |
| Shares Outstanding Peers |
| Reneo Pharmaceuticals (RPHM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RPID Shares Outstanding History RPRX Shares Outstanding History RSLS Shares Outstanding History RTIX Shares Outstanding History RTRX Shares Outstanding History RTTR Shares Outstanding History RUBY Shares Outstanding History RVMD Shares Outstanding History RVNC Shares Outstanding History RVPH Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.